Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis

Journal of Proteome Research

Volumn 13, Issue 2, 2014, Pages 395-407

  Porterfield, Mindy ^a   Zhao, Peng ^a   Han, Haiyong ^c   Cunningham, John ^d   Aoki, Kazuhiro ^a   Von Hoff, Daniel D ^c   Demeure, Michael J ^c   Pierce, J Michael ^a,b   Tiemeyer, Michael ^a,b   Wells, Lance ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b University of Georgia   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

biomarker; glycomics; N linked glycan; pancreatic cancer; proteomics

Indexed keywords

ADENOCARCINOMA; BODY FLUIDS; CARBOHYDRATE METABOLISM; CARCINOMA, PANCREATIC DUCTAL; CHROMATOGRAPHY, REVERSE-PHASE; GLYCOMICS; HUMANS; PANCREAS; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 84893818437     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400422g     Document Type: Article

References (67)

1. American Cancer Society Cancer Facts & Figures 2010. American Cancer Society: Atlanta, GA, 2010; pp 1-66.
2. Bernhard, J.; Dietrich, D.; Glimelius, B.; Hess, V.; Bodoky, G.; Scheithauer, W.; Herrmann, R. Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy Br. J. Cancer 2010, 103 (9) 1318-24
3. Magnani, J. L.; Steplewski, Z.; Koprowski, H.; Ginsburg, V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin Cancer Res. 1983, 43 (11) 5489-92
4. Xue, A.; Scarlett, C. J.; Chung, L.; Butturini, G.; Scarpa, A.; Gandy, R.; Wilson, S. R.; Baxter, R. C.; Smith, R. C. Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis Br. J. Cancer 2010, 103 (3) 391-400
5. Kopp, J. L.; von Figura, G.; Mayes, E.; Liu, F. F.; Dubois, C. L.; Morris, J. P. t.; Pan, F. C.; Akiyama, H.; Wright, C. V.; Jensen, K.; Hebrok, M.; Sander, M. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma Cancer Cell 2012, 22 (6) 737-50
6. Chen, R.; Brentnall, T. A.; Pan, S.; Cooke, K.; Moyes, K. W.; Lane, Z.; Crispin, D. A.; Goodlett, D. R.; Aebersold, R.; Bronner, M. P. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer Mol. Cell. Proteomics 2007, 6 (8) 1331-42
7. Chen, R.; Pan, S.; Cooke, K.; Moyes, K. W.; Bronner, M. P.; Goodlett, D. R.; Aebersold, R.; Brentnall, T. A. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis Pancreas 2007, 34 (1) 70-9
8. Chen, R.; Pan, S.; Yi, E. C.; Donohoe, S.; Bronner, M. P.; Potter, J. D.; Goodlett, D. R.; Aebersold, R.; Brentnall, T. A. Quantitative proteomic profiling of pancreatic cancer juice Proteomics 2006, 6 (13) 3871-9
9. Doyle, C. J.; Yancey, K.; Pitt, H. A.; Wang, M.; Bemis, K.; Yip-Schneider, M. T.; Sherman, S. T.; Lillemoe, K. D.; Goggins, M. D.; Schmidt, C. M. The Proteome of Normal Pancreatic Juice Pancreas 2011, 41 (2) 186-94
10. Gao, J.; Zhu, F.; Lv, S.; Li, Z.; Ling, Z.; Gong, Y.; Jie, C.; Ma, L. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer Oncol. Rep. 2010, 23 (6) 1683-92
11. Gronborg, M.; Bunkenborg, J.; Kristiansen, T. Z.; Jensen, O. N.; Yeo, C. J.; Hruban, R. H.; Maitra, A.; Goggins, M. G.; Pandey, A. Comprehensive proteomic analysis of human pancreatic juice J. Proteome Res. 2004, 3 (5) 1042-55
12. Rosty, C.; Goggins, M. Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach Methods Mol. Med. 2005, 103, 189-97
13. Comunale, M. A.; Rodemich-Betesh, L.; Hafner, J.; Wang, M.; Norton, P.; Di Bisceglie, A. M.; Block, T.; Mehta, A. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma PLoS One 2010, 5 (8) e12419
14. Marrero, J. A.; Romano, P. R.; Nikolaeva, O.; Steel, L.; Mehta, A.; Fimmel, C. J.; Comunale, M. A.; D'Amelio, A.; Lok, A. S.; Block, T. M. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma J. Hepatol. 2005, 43 (6) 1007-12
15. Nakagawa, T.; Takeishi, S.; Kameyama, A.; Yagi, H.; Yoshioka, T.; Moriwaki, K.; Masuda, T.; Matsumoto, H.; Kato, K.; Narimatsu, H.; Taniguchi, N.; Miyoshi, E. Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis J. Proteome Re.s 2010, 9 (10) 4888-96
16. Sato, Y.; Nakata, K.; Kato, Y.; Shima, M.; Ishii, N.; Koji, T.; Taketa, K.; Endo, Y.; Nagataki, S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein N. Engl. J. Med. 1993, 328 (25) 1802-6
17. Wandall, H. H.; Blixt, O.; Tarp, M. A.; Pedersen, J. W.; Bennett, E. P.; Mandel, U.; Ragupathi, G.; Livingston, P. O.; Hollingsworth, M. A.; Taylor-Papadimitriou, J.; Burchell, J.; Clausen, H. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Res. 2010, 70 (4) 1306-13
18. Aoki, K.; Perlman, M.; Lim, J.; Cantu, R.; Wells, L.; Tiemeyer, M. Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo J. Biol. Chem. 2007, 282 (12) 9127-9142
19. Harris, M. A.; Clark, J.; Ireland, A.; Lomax, J.; Ashburner, M.; Foulger, R.; Eilbeck, K.; Lewis, S.; Marshall, B.; Mungall, C.; Richter, J.; Rubin, G. M.; Blake, J. A.; Bult, C.; Dolan, M.; Drabkin, H.; Eppig, J. T.; Hill, D. P.; Ni, L.; Ringwald, M.; Balakrishnan, R.; Cherry, J. M.; Christie, K. R.; Costanzo, M. C.; Dwight, S. S.; Engel, S.; Fisk, D. G.; Hirschman, J. E.; Hong, E. L.; Nash, R. S.; Sethuraman, A.; Theesfeld, C. L.; Botstein, D.; Dolinski, K.; Feierbach, B.; Berardini, T.; Mundodi, S.; Rhee, S. Y.; Apweiler, R.; Barrell, D.; Camon, E.; Dimmer, E.; Lee, V.; Chisholm, R.; Gaudet, P.; Kibbe, W.; Kishore, R.; Schwarz, E. M.; Sternberg, P.; Gwinn, M.; Hannick, L.; Wortman, J.; Berriman, M.; Wood, V.; de la Cruz, N.; Tonellato, P.; Jaiswal, P.; Seigfried, T.; White, R. The Gene Ontology (GO) database and informatics resource Nucleic Acids Res. 2004, 32 (Database issue) D258-61
20. Zybailov, B.; Mosley, A. L.; Sardiu, M. E.; Coleman, M. K.; Florens, L.; Washburn, M. P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae J. Proteome Res. 2006, 5 (9) 2339-47
21. Zybailov, B. L.; Florens, L.; Washburn, M. P. Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors Mol. BioSyst. 2007, 3 (5) 354-60
22. Zhang, Y.; Wen, Z.; Washburn, M. P.; Florens, L. Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins Anal. Chem. 2010, 82 (6) 2272-81
23. Ciucanu, I.; Kerek, F. A simple and rapid method for the permethylation of carbohydrates Carbohydr. Res. 1984, 131, 209-217
24. Apte, A.; Meitei, N. S. Bioinformatics in glycomics: glycan characterization with mass spectrometric data using SimGlycan Methods Mol. Biol. 2010, 600, 269-81
25. Ferguson, M. W.; Wycoff, K. L.; Ayers, A. R. Use of cluster analysis with monoclonal antibodies for taxonomic differentiation of phytopathogenic fungi and for screening and clustering antibodies Curr. Microbiol. 1988, 17, 127-132
26. Pattathil, S.; Avci, U.; Baldwin, D.; Swennes, A. G.; McGill, J. A.; Popper, Z.; Bootten, T.; Albert, A.; Davis, R. H.; Chennareddy, C.; Dong, R.; O'Shea, B.; Rossi, R.; Leoff, C.; Freshour, G.; Narra, R.; O'Neil, M.; York, W. S.; Hahn, M. G. A comprehensive toolkit of plant cell wall glycan-directed monoclonal antibodies Plant Physiol. 2010, 153 (2) 514-25
27. De Reggi, M.; Capon, C.; Gharib, B.; Wieruszeski, J. M.; Michel, R.; Fournet, B. The glycan moiety of human pancreatic lithostathine. Structure characterization and possible pathophysiological implications Eur. J. Biochem. 1995, 230 (2) 503-10
28. Hilmy, A. M.; Kandeel, K. M.; Selim, N. M. Pancreatic amylase as a tumour marker for pancreatic cancer Arch. Geschwulstforsch. 1984, 54 (6) 475-82
29. Mizuno, R.; Hayakawa, T.; Noda, A. Elastase secretion in pancreatic disease Am. J. Gastroenterol. 1985, 80 (2) 113-7
30. Achilles, K.; Bednarski, P. J. Quantification of elastase-like activity in 13 human cancer cell lines and in an immortalized human epithelial cell line by RP-HPLC Biol. Chem. 2003, 384 (5) 817-24
31. Iwase, K.; Miyata, M.; Yamaguchi, T.; Kawaguchi, T.; Tanaka, Y.; Matsuda, H. Pancreatic ductal cell carcinoma producing pancreatic elastase 1 J. Surg. Oncol. 1993, 54 (3) 199-202
32. Ventrucci, M.; Pezzilli, R.; Gullo, L.; Plate, L.; Sprovieri, G.; Barbara, L. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease Dig. Dis. Sci. 1989, 34 (1) 39-45
33. Wendorf, P.; Geyer, R.; Sziegoleit, A.; Linder, D. Localization and characterization of the glycosylation site of human pancreatic elastase 1 FEBS Lett. 1989, 249 (2) 275-8
34. Wendorf, P.; Linder, D.; Sziegoleit, A.; Geyer, R. Carbohydrate structure of human pancreatic elastase 1 Biochem. J. 1991, 278 (Pt 2) 505-14
35. Wu, D.; Qian, J. M.; Deng, R. X.; Jiang, W. J.; Chen, Y. J.; Liu, X. H.; Lu, X. H. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer Chin. J. Dig. Dis. 2006, 7 (2) 117-20
36. D'Agostino, D.; Lowe, M. E. Pancreatic lipase-related protein 2 is the major colipase-dependent pancreatic lipase in suckling mice J. Nutr. 2004, 134 (1) 132-4
37. Cury-Boaventura, M. F.; Curi, R. Regulation of reactive oxygen species (ROS) production by C18 fatty acids in Jurkat and Raji cells Clin. Sci. 2005, 108 (3) 245-53
38. Cury-Boaventura, M. F.; Gorjao, R.; de Lima, T. M.; Newsholme, P.; Curi, R. Comparative toxicity of oleic and linoleic acid on human lymphocytes Life Sci. 2006, 78 (13) 1448-56
39. Cury-Boaventura, M. F.; Pompeia, C.; Curi, R. Comparative toxicity of oleic acid and linoleic acid on Jurkat cells Clin. Nutr. 2004, 23 (4) 721-32
40. Cury-Boaventura, M. F.; Pompeia, C.; Curi, R. Comparative toxicity of oleic acid and linoleic acid on Raji cells Nutrition 2005, 21 (3) 395-405
41. Finstad, H. S.; Heimli, H.; Kolset, S. O.; Drevon, C. A. Proliferation and types of killing of leukemia cell lines by very long chain polyunsaturated fatty acids Lipids 1999, 34 (Suppl) S107
42. Finstad, H. S.; Myhrstad, M. C.; Heimli, H.; Lomo, J.; Blomhoff, H. K.; Kolset, S. O.; Drevon, C. A. Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids Leukemia 1998, 12 (6) 921-9
43. Heimli, H.; Finstad, H. S.; Drevon, C. A. Necrosis and apoptosis in lymphoma cell lines exposed to eicosapentaenoic acid and antioxidants Lipids 2001, 36 (6) 613-21
44. Lima, T. M.; Kanunfre, C. C.; Pompeia, C.; Verlengia, R.; Curi, R. Ranking the toxicity of fatty acids on Jurkat and Raji cells by flow cytometric analysis Toxicol. In Vitro 2002, 16 (6) 741-7
45. Hayakawa, T.; Kondo, T.; Shibata, T.; Kitagawa, M.; Ono, H.; Sakai, Y.; Kiriyama, S. Enzyme immunoassay for serum pancreatic lipase in the diagnosis of pancreatic diseases Gastroenterol. Jpn. 1989, 24 (5) 556-60
46. Denizot, Y.; Chianea, T.; Labrousse, F.; Truffinet, V.; Delage, M.; Mathonnet, M. Platelet-activating factor and human thyroid cancer Eur. J. Endocrinol. 2005, 153 (1) 31-40
47. Dong, Q.; Patel, M.; Scott, K. F.; Graham, G. G.; Russell, P. J.; Sved, P. Oncogenic action of phospholipase A2 in prostate cancer Cancer Lett. 2006, 240 (1) 9-16
48. Graff, J. R.; Konicek, B. W.; Deddens, J. A.; Chedid, M.; Hurst, B. M.; Colligan, B.; Neubauer, B. L.; Carter, H. W.; Carter, J. H. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade Clin. Cancer Res. 2001, 7 (12) 3857-61
49. Jiang, J.; Neubauer, B. L.; Graff, J. R.; Chedid, M.; Thomas, J. E.; Roehm, N. W.; Zhang, S.; Eckert, G. J.; Koch, M. O.; Eble, J. N.; Cheng, L. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma Am. J. Pathol. 2002, 160 (2) 667-71
50. Laye, J. P.; Gill, J. H. Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discovery Today 2003, 8 (15) 710-6
51. Sved, P.; Scott, K. F.; McLeod, D.; King, N. J.; Singh, J.; Tsatralis, T.; Nikolov, B.; Boulas, J.; Nallan, L.; Gelb, M. H.; Sajinovic, M.; Graham, G. G.; Russell, P. J.; Dong, Q. Oncogenic action of secreted phospholipase A2 in prostate cancer Cancer Res. 2004, 64 (19) 6934-40
52. Tribler, L.; Jensen, L. T.; Jorgensen, K.; Brunner, N.; Gelb, M. H.; Nielsen, H. J.; Jensen, S. S. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue Anticancer Res. 2007, 27 (5A) 3179-85
53. Yamashita, J.; Ogawa, M.; Sakai, K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer Surgery 1995, 117 (6) 601-8
54. Yamashita, S.; Ogawa, M.; Sakamoto, K.; Abe, T.; Arakawa, H.; Yamashita, J. Elevation of serum group II phospholipase A2 levels in patients with advanced cancer Clin. Chim. Acta 1994, 228 (2) 91-9
55. Yamashita, S.; Yamashita, J.; Ogawa, M. Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br. J. Cancer 1994, 69 (6) 1166-70
56. Yamashita, S.; Yamashita, J.; Sakamoto, K.; Inada, K.; Nakashima, Y.; Murata, K.; Saishoji, T.; Nomura, K.; Ogawa, M. Increased expression of membrane-associated phospholipase A2 shows malignant potential of human breast cancer cells Cancer 1993, 71 (10) 3058-64
57. Scheele, G. A.; Fukuoka, S.; Freedman, S. D. Role of the GP2/THP family of GPI-anchored proteins in membrane trafficking during regulated exocrine secretion Pancreas 1994, 9 (2) 139-49
58. Rampoldi, L.; Scolari, F.; Amoroso, A.; Ghiggeri, G.; Devuyst, O. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease Kidney Int. 2011, 80 (4) 338-47
59. Matsumoto, Y.; Imai, Y.; Sugita, Y.; Tanaka, T.; Tsujimoto, G.; Saito, H.; Oshida, T. CCDC132 is highly expressed in atopic dermatitis T cells Mol. Med. Rep. 2010, 3 (1) 83-7
60. Sekikawa, A.; Fukui, H.; Fujii, S.; Ichikawa, K.; Tomita, S.; Imura, J.; Chiba, T.; Fujimori, T. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells Carcinogenesis 2008, 29 (1) 76-83
61. Usami, S.; Motoyama, S.; Koyota, S.; Wang, J.; Hayashi-Shibuya, K.; Maruyama, K.; Takahashi, N.; Saito, H.; Minamiya, Y.; Takasawa, S.; Ogawa, J.; Sugiyama, T. Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells Biochem. Biophys. Res. Commun. 2010, 392 (1) 4-8
62. Yamagishi, H.; Fukui, H.; Sekikawa, A.; Kono, T.; Fujii, S.; Ichikawa, K.; Tomita, S.; Imura, J.; Hiraishi, H.; Chiba, T.; Fujimori, T. Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers Mod. Pathol. 2009, 22 (7) 906-13
63. Zhou, L.; Zhang, R.; Wang, L.; Shen, S.; Okamoto, H.; Sugawara, A.; Xia, L.; Wang, X.; Noguchi, N.; Yoshikawa, T.; Uruno, A.; Yao, W.; Yuan, Y. Up-regulation of REG Ialpha accelerates tumor progression in pancreatic cancer with diabetes Int. J. Cancer 2010, 127 (8) 1795-803
64. Adamczyk, B.; Tharmalingam, T.; Rudd, P. M. Glycans as cancer biomarkers Biochim. Biophys. Acta 2011, 1820 (9) 1347-53
65. Cazet, A.; Julien, S.; Bobowski, M.; Burchell, J.; Delannoy, P. Tumour-associated carbohydrate antigens in breast cancer Breast Cancer Res 2010, 12 (3) 204
66. Reis, C. A.; Osorio, H.; Silva, L.; Gomes, C.; David, L. Alterations in glycosylation as biomarkers for cancer detection J. Clin. Pathol. 2010, 63 (4) 322-9
67. Sarrats, A.; Saldova, R.; Pla, E.; Fort, E.; Harvey, D. J.; Struwe, W. B.; de Llorens, R.; Rudd, P. M.; Peracaula, R. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis Proteomics: Clin. Appl. 2010, 4 (4) 432-48